Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

MarketWise, Inc. (the "Company" or "MarketWise") has appointed Amber Mason to
serve as Chief Operating Officer of the Company, effective as of January 10,
2023. Ms. Mason, age 43, joined MarketWise in 2006, and has worked at multiple
levels of the business. Since April 1, 2022, Ms. Mason has served as Vice
President, Business Development. She previously served as Managing Partner of
Legacy Research Group, a leading subsidiary of the Company, from January 2016 to
August 2021.

In connection with Ms. Mason's appointment as Chief Operating Officer, the
Compensation Committee of the Company's Board of Directors (the "Committee")
approved an annual base salary for Ms. Mason equal to $500,000, pro-rated for
her part-time employment status. Ms. Mason will also be eligible for a
discretionary cash bonus for 2023. In addition, in connection with her
appointment as Chief Operating Officer, Ms. Mason has been designated by the
Committee as a participant in the Company's Executive Severance Plan which was
adopted on December 16, 2022 (the "Severance Plan"), pursuant to which, in the
event of the termination of Ms. Mason's employment by the Company without Cause
or Ms. Mason's resignation for Good Reason (each as defined in the Severance
Plan), Ms. Mason will be entitled to receive (i) a lump-sum cash payment equal
to 1.25 times her base salary (1.5 times her base salary if such termination
occurs during the Change in Control Protection Period (as defined in the
Severance Plan)), (ii) a pro-rated portion of her Target Cash Bonus (as defined
in the Severance Plan) for the year of termination (1.5 times her Target Cash
Bonus if such termination occurs during the Change in Control Protection
Period), (iii) healthcare continuation coverage or reimbursement of premiums for
18 months following termination, and (iv) continued vesting of outstanding
time-based equity awards (acceleration of vesting of outstanding time-based
equity awards if such termination occurs during the Change in Control Protection
Period), in each case, subject to Ms. Mason's execution and non-revocation of a
release of claims and Ms. Mason's continued compliance with applicable
restrictive covenants, including 18 month post-termination non-competition and
non-solicitation covenants and perpetual confidentiality covenants. The
Severance Plan also provides that, in the event of the termination of Ms.
Mason's employment due to death or Disability (as defined in the Severance
Plan), Ms. Mason will be entitled to receive (i) healthcare continuation
coverage or reimbursement of premiums for 18 months following termination, and
(ii) acceleration of vesting of outstanding time-based equity awards. The
foregoing description of the applicable terms and conditions of the Severance
Plan is qualified in its entirety by the full text of the Severance Plan, which
is filed as Exhibit 10.1 hereto and incorporated herein by reference.

There are no arrangements or understandings between Ms. Mason and any other person pursuant to which Ms. Mason was selected as an officer. There are no transactions in which Ms. Mason has an interest requiring disclosure under Item 404(a) of Regulation S-K.

Item 9.01. Financial Statements and Exhibits.



(d)Exhibits.

Exhibit No.              Description

10.1                       MarketWise, Inc. Executive Severance Plan

104                      Cover Page Interactive Data File (embedded within

the Inline XBRL document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses